GNAS and neoplasm: In about 40% of patients with growth hormone secreting pituitary adenomas, constitutively activating Gsα missense mutations at either Arg201 or Gln227 have been identified in DNA from the tumor tissue, but not in DNA from peripheral blood [20, 97].